Bactrim (co-trimoxazole) is a fixed-dose combination of trimethoprim and sulfamethoxazole that works through sequential inhibition of bacterial folate synthesis, producing synergistic bactericidal activity and broad-spectrum antimicrobial coverage. This video explains the mechanism of action in detail, including inhibition of dihydropteroate synthase and dihydrofolate reductase, and how disruption of folate metabolism impairs bacterial DNA and RNA synthesis. Learn which organisms are commonly covered—including Staphylococcus aureus (including some MRSA strains), E. coli, Klebsiella, Haemophilus influenzae, Nocardia, Pneumocystis jirovecii, and Toxoplasma gondii—and which pathogens are poorly covered, such as Pseudomonas aeruginosa, Enterococcus species, most anaerobes, and atypical organisms. The video reviews important clinical indications including urinary tract infections, prostatitis, Pneumocystis jirovecii pneumonia (PJP) treatment and prophylaxis, nocardiosis, cyclosporiasis, and selected skin and soft tissue infections. Gain practical insight into pharmacokinetics, including high oral bioavailability, wide tissue distribution, renal elimination, and the need for dose adjustment in renal impairment. The discussion also covers mechanisms of bacterial resistance, common adverse effects such as gastrointestinal upset, rash, hypersensitivity reactions, hyperkalemia, and elevated serum creatinine, as well as serious complications including Stevens–Johnson syndrome, toxic epidermal necrolysis, aplastic anemia, hemolytic anemia, nephrotoxicity, and hepatotoxicity. Finally, learn the key contraindications, drug interactions, and monitoring considerations—including pregnancy, G6PD deficiency, severe renal or hepatic disease, sulfonamide allergy, and interactions with warfarin, ACE inhibitors, ARBs, potassium-sparing diuretics, and methotrexate. Clear, clinically focused, and practical, this video equips medical students, clinicians, and healthcare professionals with the knowledge needed to prescribe Bactrim safely and effectively while recognizing important adverse effects and monitoring requirements.
